ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

3-キヌクリジノール

(+-)-3-Quinuclidinol

HCID 15381
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
1619-34-7
標準SMILES
OC1CN2CCC1CC2
InChIKey
IVLICPVPXWEGCA-UHFFFAOYSA-N
分子式
C7H13NO
平均分子量
127.18 g/mol
単同位体質量
127.09971404

概要

3-quinuclidinol is quinuclidine in which a hydrogen atom at position 3 is substituted by a hydroxy group. It is a member of quinuclidines, a tertiary amine and a secondary alcohol.

名称と識別子

優先名称
(+-)-3-Quinuclidinol
IUPAC
1-azabicyclo[2.2.2]octan-3-ol
現地名
3-キヌクリジノール
英語名
3-Quinuclidinol
分子式
C7H13NO
分子量
127.18

名称と別名

3-QUINUCLIDINOL1619-34-73-Hydroxyquinuclidine1-Azabicyclo[2.2.2]octan-3-ol(+-)-3-quinuclidinol1-Azabicyclo(2.2.2)octan-3-ol974MVZ0WOKNSC-93905CHEBI:115239DTXSID508627163-Quinuclidinol dl-RefChem:505290
名称をさらに表示
3-キヌクリジノール3-ヒドロキシキヌクリジン1-アザビシクロ[2.2.2]オクタン-3-オールキヌクリジン-3-オール3‐キヌクリジノール1,4-エタノピペリジン-3-オール(3R)-1-azabicyclo[2.2.2]octan-3-ol (3-quinuclidinol)BENC-002Quinuclidinol-3
DTXCID60218745216-578-4Quinuclidin-3-olQuinuclidinol1-Aza-bicyclo[2.2.2]octan-3-ol3-Hydroxy-1-azabicyclo[2.2.2]octaneQuinuclidine-3-olNSC 93905

データベース識別子

CAS
1619-34-7
PubChem CID
15381
DTXSID
DTXSID50862716
ChEMBL
CHEMBL276310
ChEBI
CHEBI:115239
UNII
974MVZ0WOK
EC Number
216-578-4
Nikkaji
J84.997I

物性

構造計算による物性

XLogP
0.2
極性表面積
23.5 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
0
重原子数
9
形式電荷
0
複雑度
107

実験および物理化学的性質

Color/Form · 3 件

Cream colored crystalline powder

Crystals form in ethanol

Crystals form in benzene

Boiling PointSublimes at 120 °C
DecompositionWhen heated to decomposition it emits toxic vapors of /nitrogen oxides/.
Melting Point221 °C

物理化学的性質

融点
220 · 220-223 °C(lit.)
沸点
235.98 °C · 235.98°C (rough estimate)
比重(密度)
1.0083 · 1.0083 (rough estimate)
屈折率
1.479 · 1.4790 (estimate)
貯蔵温度
2 · 2-8°C
溶解性
Aqueous Acidic (Slightly), Chloroform (Sparingly), Methanol (Slightly)
外見
結晶性粉末
酸解離定数(Pka)
14.75 · 14.75±0.20(Predicted)
色
白からベージュ
水溶解度
溶ける
Merck
14 · 14,8082

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H314 (94.2%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 52 reports by companies from 6 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory InformationStatus: Active Update: 29-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/20675
Hazard Classes and CategoriesSkin Corr. 1B (94.2%)

安全と保護具

Fire Fighting Procedures · 2 件

Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.

EXTINGUISHING MEDIA Suitable: Water spray. Carbon dioxide, dry chemical powder, or appropriate foam.

Storage ConditionsKeep tightly closed
Cleanup Methods · 1 件

Procedure to be followed in case of leak or spill: Evacuate area. Personal precautions: Wear self-contained breathing apparatus, rubber boots, and heavy rubber gloves. Methods for cleaning up: Sweep up, place in a bag and hold for waste disposal. Ventilate area and wash spill site after material pickup is complete.

Disposal Methods · 2 件

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

化学と産業

薬理情報

Metabolism/Metabolites3-Quinuclidinol (Q) and benzilic acid (BA) /are the 2 major metabolites of 3-quinuclidinyl benzilate/.

用途と製造

Uses · 5 件

Precursor in the synthesis of chemical warfare agent 3-quinuclidinyl benzilate (BZ)

Used in the manufacture of pharmaceuticals

Benzilate (ester) has been used as an incapacitating agent in chemical warfare.

THERAP CAT: Hypotensive; acetate (ester) as cholinergic

... Precursor to BZ and Arsenic trichloride.

Methods of Manufacturing · 2 件

Synthesis: 3-Quinuclidinone hydrochloride and hydrogen

Sternbach, US 2648667 (1953 to Hoffmann-La Roche)

General Manufacturing Information · 3 件

1-Azabicyclo[2.2.2]octan-3-ol: ACTIVE

Used in the synthesis of anticholinergic drug clidinium bromide /Clidinium bromide/

Used in the synthesis of antihypotensive drug aceclidine /Aceclidine/

応用分野 · 1 件

使用3-Quinuclidinol acts as a chiral building block for various antimuscarinic agents and other active pharmaceutical ingredients. It serves as a catalyst for condensation of methyl vinyl ketone with aldehydes. It is also used as a reagent for cleavage of beta-keto and vinylogous beta-keto esters. Further, it plays an important role as a synthon in the preparation of cholinergic receptor ligands and anesthetics. In addition to this, it is used in chemoselective alfa-iodination of acrylic esters through Morita-Baylis-Hillman reaction.

補足説明

定義ChEBI: Quinuclidine in which a hydrogen atom at position 3 is substituted by a hydroxy group.

関連反応

246 件
反応記録を作成
HRID 914 の反応式
HRID 914反応物として
HRID 5112 の反応式
HRID 5112反応物として
HRID 38796 の反応式
HRID 38796反応物として
HRID 77410 の反応式
HRID 77410反応物として
HRID 90312 の反応式
HRID 90312反応物として
HRID 94411 の反応式
HRID 94411反応物として
HRID 104229 の反応式
HRID 104229反応物として
HRID 111294 の反応式
HRID 111294反応物として
前へ1 / 31 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
BRN
104327 · 104327
Henry's Law Constant
1.7 · 1.7×103 mol/(m3Pa) at 25℃, Du et al. (2017)
LogP
0.17 · 0.17
CAS データベース
1619 · 1619-34-7(CAS DataBase Reference)
NISTの化学物質情報
3 · 3-Quinuclidinol(1619-34-7)
EPAの化学物質情報
1 · 1-Azabicyclo[2.2.2]octan-3-ol (1619-34-7)

化学的性質

化学的特性Crystalline Solid

Contact a licensed professional waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Observe all federal, state, and local environmental regulations.

Preventive Measures · 4 件

In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing, gloves, and eye/face protection. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).

Wash contaminated clothing before reuse. Discard contaminated shoes. Wash thoroughly after handling.

Do not breathe dust. Do not get in eyes, on skin, on clothing. Avoid prolonged or repeated exposure.

SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants.

Personal Protective Equipment (PPE) · 2 件

Engineering Controls. Safety shower and eye bath. Use only in a chemical fume hood.

Personal Protective Equipment. Respiratory: Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Hand: Compatible chemical-resistant gloves. Eye: Chemical safety goggles.

Other Standards Regulations and Guidelines · 1 件

/The Chemical Weapons Convention (CWC) is an international treaty which bans the development, production, stockpiling, and transfer or use of chemical weapons. The Convention mandates the destruction and prohibition of chemical weapons and related facilities and provides for restrictions on international trade in toxic chemicals and precursors./ The Convention's monitoring and verification measures involve submission of declarations regarding ... /Schedule 1, 2, and 3 chemicals/ and inspections by the Organization for the Prohibition of Chemical Weapons of the facilities where these chemicals are produced. ... Schedule 2 lists toxic chemicals and precursors deemed to pose a significant risk to the object and purpose of the CWC because of their lethal or incapacitating properties. Precursors may be used in the final stage for formation, or may be important for the production, of any of the chemicals listed in Schedule 1 or toxic chemicals listed in Schedule 2. Schedule 2 chemicals are not produced in large quantities for commercial ... purposes ... but may be used to manufacture such things as insecticides, herbicides, lubricants or pharmaceutical products (2). Quinuclidin-3-ol is listed in the CWC Annex on Chemicals under Schedule 2 (1).

毒性情報

Environmental Fate · 3 件

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 8(SRC), determined from a structure estimation method(2), indicates that 3-quinuclidinol is expected to have very high mobility in soil(SRC). Volatilization of 3-quinuclidinol from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 8.1X10-10 atm-cu m/mole(SRC), using a fragment constant estimation method(3). 3-Quinuclidinol is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.3X10-4 mm Hg(SRC), determined from a fragment constant method(4). Biodegradation data for 3-quinuclidinol were not available(SRC, 2009).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 8(SRC), determined from a structure estimation method(2), indicates that 3-quinuclidinol is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 8.1X10-10 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). According to a classification scheme(5), an estimated BCF of 3.2(SRC), from an estimated log Kow of 0.17(6) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data for 3-quinuclidinol were not available(SRC, 2009).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 3-quinuclidinol , which has an estimated vapor pressure of 3.3X10-4 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase 3-quinuclidinol is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 2.3 hours(SRC), calculated from its rate constant of 5.5X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). 3-quinuclidinol does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not susceptible to direct photolysis by sunlight(SRC).

Soil Adsorption/Mobility · 1 件

Using a structure estimation method based on molecular connectivity indices(1), the Koc of 3-quinuclidinol can be estimated to be 8(SRC). According to a classification scheme(2), this estimated Koc value suggests that 3-quinuclidinol is expected to have very high mobility in soil.

Human Toxicity Excerpts · 3 件

/SIGNS AND SYMPTOMS/ Skin Contact: Causes burns. Skin Absorption: May be harmful if absorbed through the skin. Eye Contact: Causes burns. Inhalation: May be harmful if inhaled. Material is extremely destructive to the tissue of the mucous membranes and upper respiratory tract. Ingestion: May be harmful if swallowed.

/SIGNS AND SYMPTOMS/ Inhalation may result in spasm, inflammation and edema of the larynx and bronchi, chemical pneumonitis, and pulmonary edema. Symptoms of exposure may include burning sensation, coughing, wheezing, laryngitis, shortness of breath, headache, nausea, and vomiting. Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and skin.

/OTHER TOXICITY INFORMATION/ Corrosive.

Artificial Pollution Sources · 1 件

3-Quinuclidinol's production and use as a precursor in the synthesis of chemical warfare agent 3-quinuclidinyl benzilate (BZ)(1) in the manufacture of pharmaceuticals(1), synthesis of anticholinergic drug clidinium bromide(2), and synthesis of antihypotensive drug aceclidine(2) may result in its release to the environment through various waste streams(SRC).

Environmental Bioconcentration · 1 件

An estimated BCF of 3.2 was calculated for 3-quinuclidinol(SRC), using an estimated log Kow of 0.17(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC).

Volatilization from Water/Soil · 1 件

The Henry's Law constant for 3-quinuclidinol is estimated as 8.1X10-10 atm-cu m/mole at 25 °C(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that 3-quinuclidinol is expected to be essentially nonvolatile from water surfaces(2). The Henry's Law constant of 3-quinuclidinol indicates that volatilization from moist soil surfaces will not occur(SRC). 3-Quinuclidinol is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.3X10-4 mm Hg at 25 °C(SRC), determined from a fragment constant method(3).

Non-Human Toxicity Excerpts · 2 件

/ALTERNATIVE and IN VITRO TESTS/ The preparation of R-(-)-3-quinuclidinol and its acetate ester is reported. These compounds, together with their racemates, were tested as inhibitors and substrates of the enzyme acetylcholinesterase. The results suggest that the enzyme active site is stereospecific toward R-(-)-3-quinuclidinol hydrochloride when acting as an inhibitor. Both (+/-)- and R-(-)-3-acetoxyquinuclidine hydrochloride are substrates of the enzyme, but the S-enantiomer probably has some affinity for the enzyme also.

/ALTERNATIVE and IN VITRO TESTS/ Choline uptake into cholinergic neurons for acetylcholine (ACh) synthesis is by a specific, high-affinity, sodium- and temperature-dependent transport mechanism (HAChU). To assess the role of choline availability in regulation of ACh synthesis, the structure-activity relationships of several ... quinuclidinyl analogs were evaluated in a dose response manner. ... The most potent quinuclidinyl derivative was the N-methyl-3-quinuclidinone (I50 = 5.6 X 10-7 M). This compound had approximately 100-fold greater inhibitory activity than the corresponding racemic alcohol, suggesting that the 3-hydroxyl functional group is not absolutely essential for activity. Increasing the size of the N-functional group from a methyl to an allyl in the alcohol led to a 10-fold increase in activity. However, removal of the quaternizing N-methyl group yielding the tertiary amine, 3-quinuclidinol hydrochloride, greatly reduced its capacity to inhibit HAChU. Of the 2-benzylidene-3-quinuclidinone derivatives studied, only the m-chloro derivative significantly reduced HAChU. /3-Quinuclidinol hydrochloride/

Environmental Abiotic Degradation · 1 件

The rate constant for the vapor-phase reaction of 3-quinuclidinol with photochemically-produced hydroxyl radicals has been estimated as 5.5X10-11 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 2.3 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). 3-Quinuclidinol is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(3). 3-Quinuclidinol does not contain chromophores that absorb at wavelengths >290 nm(3) and therefore is not susceptible to direct photolysis by sunlight(SRC).

Probable Routes of Human ExposureOccupational exposure to 3-quinuclidinol may occur through inhalation of dust and dermal contact at workplaces where it is produced or used. (SRC)
Environmental Fate/Exposure Summary · 1 件

3-Quinuclidinol's production and use as a synthetic precursor to chemical warfare agents and drugs may result in its release to the environment through various waste streams. If released to air, an estimated vapor pressure of 3.3X10-4 mm Hg at 25 °C indicates 3-quinuclidinol will exist solely as a vapor in the atmosphere. Vapor-phase 3-quinuclidinol will be degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals; the half-life for this reaction in air is estimated to be 2.3 hours. 3-Quinuclidinol does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight. If released to soil, 3-quinuclidinol is expected to have very high mobility based upon an estimated Koc of 8. Volatilization from moist soil surfaces is not expected to be an important fate process based upon an estimated Henry's Law constant of 8.1X10-10 atm-cu m/mole. 3-Quinuclidinol is not expected to volatilize from dry soil surfaces based upon its vapor pressure. If released into water, 3-quinuclidinol is not expected to adsorb to suspended solids and sediment based upon the Koc. Volatilization from water surfaces is not expected to be an important fate process based upon Henry's Law constant of 3-quinuclidinol. An estimated BCF of 3.2 suggests the potential for bioconcentration in aquatic organisms is low. Hydrolysis is not expected to be an important environmental fate process since 3-quinuclidinol lacks functional groups that hydrolyze under environmental conditions. Occupational exposure to 3-quinuclidinol may occur through inhalation of dust and dermal contact at workplaces where it is produced or used. (SRC)

Antidote and Emergency Treatment · 3 件

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand-valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR as necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Incapacitating Agents/

/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations it necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . Demonstrate a friendly attitude and use firm restraint when necessary. All dangerous objects must be removed from the area and anything likely to be swallowed should be kept away from patients, because bizarre delusions may occur. For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Use rapid cooling techniques to manage hyperthermia ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. Administer activated charcoal ... . /Incapacitating Agents/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag-valve-mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors if patient is hypotensive with a normal fluid volume. Watch for signs of fluid overload ... . Treat seizures or sedate LSD patients with diazepam (Valium) or lorazepam (Ativan) ... . Administer physostigmine for symptomatic BZ or Agent 15 exposure only .... . Use proparacaine hydrochloride to assist eye irrigation ... . /Incapacitating Agents/

安全データ

F
34
wgk
3
tsca
TSCA listed
rtecs
VD6191700
ridadr
UN 3263 8/PG 2
hs_code
2933392000
risk_code
34-11
化審法
(5)-6850
hazard_code
C,F
hazard_note
Corrosive
safety_code
26-36/37/39-45-16
hazard_class
8
packing_group
III
有毒物質データの
1619-34-7(Hazardous Substances Data)